Introduction
Pulmonary alveolar proteinosis, a rare pulmonary disorder, was first described by Rosen et al in 1958 (1) . It is characterised by abnormal accumulation of surfactant derived substances in the alveoli, due to a defect either in the production of surfactant or the clearance by alveolar macrophages, which explains the high association with malignancies and unusual infections. Those affected could have mild symptoms, spontaneous resolution or progressive disease with respiratory failure.
Case report
A 35-year-old female presented with progressively worsening exertional dyspnoea for six months. She also complained of chronic cough, low grade fever for two months, pleuritic-type chest pain, loss of appetite, fatigue, malaise and a marked weight loss (27 kg over 6 months). She gave a history of exposure to dust at her domestic employment of manufacturing bricks. She had never smoked but exposed to passive smoking at home. Screening for tuberculosis in the previous month had been negative. Despite the negative tests, she had been treated with specific anti-TB drugs owing to the nature of the symptoms and other findings.
On physical examination, she was afebrile, tachypnoeic, centrally cyanosed with a SaO of 65% 2 on air. There were few scattered crepitations bilaterally.
Arterial blood gas analysis revealed Type I respiratory failure with PCO 29 mmHg and PO 2 2 63mmHg. Lung function tests showed restrictive lung disease ( Figure 1 ).
Figure 1: Chest radiograph showing bilateral interstitial and alveolar shadows
Sputum for gram stain and culture didn't show any pathogens and three sputum samples were negative for acid fast bacilli. There were no malignant cells in sputum cytology. Her lactate dehydrogenase was 397 U/L (85 -234) and HIV I and II antibodies were negative. Other laboratory tests revealed normal haematological parameters with normal kidney and liver functions ( Figure 2 ).
Her bronchoalveolar lavage fluid analysis showed numerous, round to irregular, hyaline periodic acid Schiff (PAS) positive casts. After evaluating her clinical, radiological and histological information the diagnosis of primary pulmonary alveolar proteinosis was made.
She was managed, initially, with high flow oxygen to maintain the SaO 92% and subsequently whole lung 2 lavage under anaesthesia. After two cycles of lavage therapy her functional capacity improved and oxygen saturation improved markedly (96% on air). 
Discussion
Pulmonary alveolar proteinosis (PAP) is a rare disease with a prevalence of a 0.1 per 100,000 population. It occurs in all age groups and most common in men (male : female 4 : 1) and among people aged 20 to 50 years. The disease is commoner among smokers (3 times) than among non-smokers.
There are three clinically distinct forms of PAP. They include congenital (2%), primary (90%) and secondary (5-10% (4) . In conclusion, the differential diagnosis of PAP should be considered in a patient who comes with chronic cough and dyspnoea in whom initial investigations negative for common causes. A common mistake is to treat them as pulmonary tuberculosis leading to delay in correct diagnosis and specific treatment. Although pulmonary tuberculosis is a common disease, the possibility of PAP should be considered when laboratory tests fail to confirm TB etiology and the expected therapeutic response with anti-TB drugs is not seen during the follow up.
